Pathways that were revealed to be activated in pre-cDC1s included several pathways regulating cell cycle control, oxidative phosphorylation, and the PD-1/PD-L1 cancer immunotherapy pathway (Fig 6C). This evidence concerns the gene CD274 and cancer.